The future of US healthcare is being created today in Medicare's demonstration programs. But how you respond to them depends a lot on what kind of company you are.
Erik Felker
Advertisement
Articles by Erik Felker
Advertisement
Latest Updated Articles
Elephant or Specialist?Published: May 1st 2005 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
2
What Impact will DTC Programs have on Generic Drug Prices?
3
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
4
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
5
